US Patent 7985409 Tr1 cells for use in atherosclerosis
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+418 characters)
Article
Patent abstract
The present invention relates to a method of treating or preventing atherosclerosis comprising administering to a mammal in need of such a treatment a) an antigen which has been used to activate in vitro a Tri cell population originating from said mammal, and b) the TO cell population activated by said antigen, said TO cell population being obtained from a CD4+ T lymphocyte population of said mammal.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Alain Tedgui0
Hervé Groux0
Valérie Brun0
Ziad Mallat0
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07985409 Tr1 cells for use in atherosclerosis US Patent 7985409 Tr1 cells for use in atherosclerosis
Infobox
Patent Number
07985409
Patent Number
7985409
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07985409 Tr1 cells for use in atherosclerosis
Infobox
Is a
Patent jurisdiction
Patent number
07985409
Date of patent
July 26, 2011
Patent application number
11660113
Date Filed
August 11, 2004
Patent primary examiner
Find more entities like US Patent 7985409 Tr1 cells for use in atherosclerosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.